Mitochondrial biogenesis through activation of nuclear signaling proteins

Cold Spring Harbor Perspectives in Biology

Volumn 5, Issue 7, 2013, Pages

  Dominy, John E ^a   Puigserver, Pere ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL PROTEIN; NUCLEAR PROTEIN;

ARTICLE; BIOLOGICAL MODEL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MITOCHONDRIAL DYNAMICS; MITOCHONDRION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ENERGY METABOLISM; GENE EXPRESSION REGULATION; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MITOCHONDRIAL PROTEINS; MITOCHONDRIAL TURNOVER; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION;

EID: 84879777259     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a015008     Document Type: Article

References (121)

1. Ashrafi G, Schwarz TL. 2013. The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ 20: 31-42.
2. Baker BM, Haynes CM. 2011. Mitochondrial protein quality control during biogenesis and aging. Trends Biochem Sci 36: 254-261.
3. Bastin J, Lopes-Costa A, Djouadi F. 2011. Exposure to resveratrol triggers pharmacological correction of fatty acid utilization in human fatty acid oxidation-deficient fibroblasts. Hum Mol Genet 20: 2048-2057.
4. Baughman JM, Perocchi F, Girgis HS, Plovanich M, Belcher-Timme CA, Sancak Y, Bao XR, Strittmatter L, Goldberger O, Bogorad RL, et al. 2011. Integrative genomics identifies MCUas an essential component of the mitochondrial calcium uniporter. Nature 476: 341-345.
5. Beal MF. 2009. Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease. Parkinsonism Relat Disord 15 (Suppl 3): S189-S194.
6. Bianchi K, Vandecasteele G, Carli C, Romagnoli A, Szabadkai G, Rizzuto R. 2006. Regulation of Ca2+ signalling and Ca2+-mediated cell death by the transcriptional coactivator PGC-1a. Cell Death Differ 13: 586-596.
7. Birkenfeld AL, Lee HY, Guebre-Egziabher F, Alves TC, Jurczak MJ, Jornayvaz FR, Zhang D, Hsiao JJ, Martin-Montalvo A, Fischer-Rosinsky A, et al. 2011. Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice. Cell Metab 14: 184-195.
8. Blattler SM, Cunningham JT, Verdeguer F, Chim H, Haas W, Liu H, Romanino K, Ruegg MA, Gygi S, Shi Y, et al. 2012a. Yin Yang 1 deficiency in skeletal muscle protects against rapamycin-induced diabetic-like symptoms through activation of insulin/IGF signaling. Cell Metab 15: 505-517.
9. Blattler SM, Verdeguer F, Liesa M, Cunningham JT, Vogel RO, Chim H, Liu H, Romanino K, Shirihai OS, Vazquez F, et al. 2012b. Defective mitochondrial morphology and bioenergetic function in mice lacking the transcription factor Yin Yang 1 in skeletal muscle. Mol Cell Biol 32: 3333-3346.
10. Bonnefont JP, Bastin J, Behin A, Djouadi F. 2009. Bezafibrate for an inborn mitochondrial β-oxidation defect. N Engl J Med 360: 838-840.
11. Brown K, Xie S, Qiu X, Mohrin M, Shin J, Liu Y, Zhang D, Scadden DT, Chen D. 2013. SIRT3 reverses aging-associated degeneration. Cell Rep 3: 319-327.
12. Calvo SE, Mootha VK. 2010. The mitochondrial proteome and human disease. Annu Rev Genomics Hum Genet 11: 25-44.
13. Cam H, Balciunaite E, Blais A, Spektor A, Scarpulla RC, Young R, Kluger Y, Dynlacht BD. 2004. A common set of gene regulatory networks links metabolism and growth inhibition. Mol Cell 16: 399-411.
14. Cannon B, Nedergaard J. 2004. Brown adipose tissue: Function and physiological significance. Physiol Rev 84: 277-359.
15. Canto C, Auwerx J. 2009. PGC-1a, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol 20: 98-105.
16. Canto C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P, Auwerx J. 2009. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458: 1056-1060.
17. Canto C, Houtkooper RH, Pirinen E, Youn DY, Oosterveer MH, Cen Y, Fernandez-Marcos PH, Yamamoto H, Andreux PA, Cettour-Rose P, et al. 2012. The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab 15: 838-847.
18. Carter RS, Bhat NK, Basu A, Avadhani NG. 1992. The basal promoter elements of murine cytochrome c oxidase subunit IV gene consist of tandemly duplicated ets motifs that bind to GABP-related transcription factors. J Biol Chem 267: 23418-23426.
19. Cartoni R, Leger B, Hock MB, Praz M, Crettenand A, Pich S, Ziltener JL, Luthi F, Deriaz O, Zorzano A, et al. 2005. Mitofusins 1/2 and ERRa expression are increased in human skeletal muscle after physical exercise. J Physiol 567: 349-358.
20. Casas F, Rochard P, Rodier A, Cassar-Malek I, Marchal-Victorion S, Wiesner RJ, Cabello G, Wrutniak C. 1999. A variant form of the nuclear triiodothyronine receptor c-ErbAa1 plays a direct role in regulation of mitochondrial RNA synthesis. Mol Cell Biol 19: 7913-7924.
21. Chae S, Ahn BY, Byun K, Cho YM, Yu MH, Lee B, Hwang D, Park KS. 2013. A systems approach for decoding mitochondrial retrograde signaling pathways. Science Signal 6: rs4.
22. Charos AE, Reed BD, Raha D, Szekely AM, Weissman SM, Snyder M. 2012. A highly integrated and complex PPARGC1A transcription factor binding network in HepG2 cells. Genome Res 22: 1668-1679.
23. Chen H, Chan DC. 2009. Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases. Hum Mol Genet 18: R169-R176.
24. Chen H, Chan DC. 2010. Physiological functions of mitochondrial fusion. Ann NYAcad Sci 1201: 21-25.
25. Civitarese AE, Carling S, Heilbronn LK, Hulver MH, Ukropcova B, Deutsch WA, Smith SR, Ravussin E. 2007. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med 4: e76.
26. Corrado M, Scorrano L, Campello S. 2012. Mitochondrial dynamics in cancer and neurodegenerative and neuroinflammatory diseases. Int J Cell Biol 2012: 729290.
27. Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P. 2007. mTOR controls mitochondrial oxidative function through a YY1-PGC-1a transcriptional complex. Nature 450: 736-740.
28. De Stefani D, Raffaello A, Teardo E, Szabo I, Rizzuto R. 2011. A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature 476: 336-340.
29. DiMauro S, Hirano M. 2009. Pathogenesis and treatment of mitochondrial disorders. Adv Exp Med Biol 652: 139-170.
30. Dinardo MM, Musicco C, Fracasso F, Milella F, Gadaleta MN, Gadaleta G, Cantatore P. 2003. Acetylation and level of mitochondrial transcription factor A in several organs of young and old rats. Biochem Biophys Res Commun 301: 187-191.
31. Du J, Zhou Y, Su X, Yu JJ, Khan S, Jiang H, Kim J, Woo J, Kim JH, Choi BH, et al. 2011. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334: 806-809.
32. Eichner LJ, Giguere V. 2011. Estrogen related receptors (ERRs): A new dawn in transcriptional control of mitochondrial gene networks. Mitochondrion 11: 544-552.
33. Endo T, Yamano K. 2009. Multiple pathways for mitochondrial protein traffic. Biol Chem 390: 723-730.
34. Endo T, Yamano K, Kawano S. 2011. Structural insight into the mitochondrial protein import system. Biochim Biophys Acta 1808: 955-970.
35. Evans MJ, Scarpulla RC. 1989. Interaction of nuclear factors with multiple sites in the somatic cytochrome c promoter. Characterization of upstream NRF-1, ATF, and intron Sp1 recognition sequences. J Biol Chem 264: 14361-14368.
36. Finkel T, Deng CX, Mostoslavsky R. 2009. Recent progress in the biology and physiology of sirtuins. Nature 460: 587-591.
37. Gebert N, Ryan MT, Pfanner N, Wiedemann N, Stojanovski D. 2011. Mitochondrial protein import machineries and lipids: A functional connection. Biochim Biophys Acta 1808: 1002-1011.
38. Gerhart-Hines Z, Dominy JE Jr, Blattler SM, Jedrychowski MP, Banks AS, Lim JH, Chim H, Gygi SP, Puigserver P. 2011. The cAMP/PKA pathway rapidly activates SIRT1 to promote fatty acid oxidation independently of changes in NAD+. Mol Cell 44: 851-863.
39. Gleyzer N, Vercauteren K, Scarpulla RC. 2005. Control of mitochondrial transcription specificity factors (TFB1M and TFB2M) by nuclear respiratory factors (NRF-1 and NRF-2) and PGC-1 family coactivators. Mol Cell Biol 25: 1354-1366.
40. Golubitzky A, Dan P, Weissman S, Link G, Wikstrom JD, Saada A. 2011. Screening for active small molecules in mitochondrial complex I deficient patient's fibroblasts, reveals AICAR as the most beneficial compound. PloS ONE 6: e26883.
41. Gopalakrishnan L, Scarpulla RC. 1994. Differential regulation of respiratory chain subunits by a CREB-dependent signal transduction pathway. Role of cyclic AMP in cytochrome c and COXIV gene expression. J Biol Chem 269: 105-113.
42. Guarente L. 2011. Franklin H. Epstein Lecture: Sirtuins, aging, and medicine. N Engl J Med 364: 2235-2244.
43. Gugneja S, Virbasius JV, Scarpulla RC. 1995. Four structurally distinct, non-DNA-binding subunits of human nuclear respiratory factor 2 share a conserved transcriptional activation domain. Mol Cell Biol 15: 102-111.
44. Gulick T, Cresci S, Caira T, Moore DD, Kelly DP. 1994. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc Natl Acad Sci 91: 11012-11016.
45. Haigis MC, Sinclair DA. 2010. Mammalian sirtuins: Biological insights and disease relevance. Annu Rev Pathol 5: 253-295.
46. Handschin C, Spiegelman BM. 2011. PGC-1 coactivators and the regulation of skeletal muscle fiber-type determination. Cell Metab 13: 351; author reply 352.
47. Hardie DG. 2007. AMP-activated/SNF1 protein kinases: Conserved guardians of cellular energy. Nat Rev Mol Cell Biol 8: 774-785.
48. Haynes CM, Yang Y, Blais SP, Neubert TA, Ron D. 2010. The matrix peptide exporter HAF-1 signals a mitochondrial UPR by activating the transcription factor ZC376.7 in C. elegans. Mol Cell 37: 529-540.
49. Hebert AS, Dittenhafer-Reed KE, Yu W, Bailey DJ, Selen ES, Boersma MD, Carson JJ, Tonelli M, Balloon AJ, Higbee AJ, et al. 2013. Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol Cell 49: 186-199.
50. Herzig S, Long F, Jhala US, Hedrick S, Quinn F, Bauer A, Rudolph D, Schutz G, Yoon C, Puigserver P, et al. 2001. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413: 179-183.
51. Hirano M, Garone C, Quinzii CM. 2012. CoQ10 deficiencies and MNGIE: Two treatable mitochondrial disorders. Biochim Biophys Acta 1820: 625-631.
52. Hirschey MD, Shimazu T, Jing E, Grueter CA, Collins AM, Aouizerat B, Stancakova A, Goetzman E, Lam MM, Schwer B, et al. 2011. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol Cell 44: 177-190.
53. Jager S, Handschin C, St-Pierre J, Spiegelman BM. 2007. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1a. Proc Natl Acad Sci 104: 12017-12022.
54. Kaeberlein M, Powers RWIII, Steffen KK, Westman EA, Hu D, Dang N, Kerr EO, Kirkland KT, Fields S, Kennedy BK. 2005. Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science 310: 1193-1196.
55. Kahn BB, Alquier T, Carling D, Hardie DG. 2005. AMPactivated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1: 15-25.
56. Kelly DP, Scarpulla RC. 2004. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev 18: 357-368.
57. Klar AJ, Fogel S, Macleod K. 1979. MAR1-A regulator of the HMa and HMa loci in Saccharomyces cerevisiae. Genetics 93: 37-50.
58. Kleiner S, Nguyen-Tran V, Bare O, Huang X, Spiegelman B, Wu Z. 2009. PPARd agonism activates fatty acid oxidation via PGC-1a but does not increase mitochondrial gene expression and function. J Biol Chem 284: 18624-18633.
59. Libri V, Brown AP, Gambarota G, Haddad J, Shields GS, Dawes H, Pinato DJ, Hoffman E, Elliot PJ, Vlasuk GP, et al. 2012. A pilot randomized, placebo controlled, double blind phase I trial of the novel SIRT1 activator SRT2104 in elderly volunteers. PloS ONE 7: e51395.
60. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, et al. 2002. Transcriptional co-activator PGC-1 a drives the formation of slowtwitch muscle fibres. Nature 418: 797-801.
61. Liu Z, Butow RA. 2006. Mitochondrial retrograde signaling. Annu Rev Genet 40: 159-185.
62. Lopez-Lluch G, Hunt N, Jones B, Zhu M, Jamieson H, Hilmer S, Cascajo MV, Allard J, Ingram DK, Navas P, et al. 2006. Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. Proc Natl Acad Sci 103: 1768-1773.
63. Lu B, Lee J, Nie X, Li M, Morozov YI, Venkatesh S, Bogenhagen DF, Temiakov D, Suzuki CK. 2013. Phosphorylation of human TFAM in mitochondria impairs DNA binding and promotes degradation by the AAA+ Lon protease. Mol Cell 49: 121-132.
64. Mayr B, Montminy M. 2001. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2: 599-609.
65. Miller BF, Robinson MM, Bruss MD, Hellerstein M, Hamilton KL. 2012. A comprehensive assessment of mitochondrial protein synthesis and cellular proliferation with age and caloric restriction. Aging Cell 11: 150-161.
66. Minor RK, Baur JA, Gomes AP, Ward TM, Csiszar A, Mercken EM, Abdelmohsen K, Shin YK, Canto C, Scheibye-Knudsen M, et al. 2011. SRT1720 improves survival and healthspan of obese mice. Scientific Rep 1: 70.
67. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, et al. 2003. PGC-1a-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273.
68. Mootha VK, Handschin C, Arlow D, Xie X, St Pierre J, Sihag S, Yang W, Altshuler D, Puigserver P, Patterson N, et al. 2004. Erra and Gabpa/b specify PGC-1a-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci 101: 6570-6575.
69. Nakagawa T, Lomb DJ, Haigis MC, Guarente L. 2009. SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 137: 560-570.
70. Narendra D, Walker JE, Youle R. 2012. Mitochondrial quality control mediated by PINK1 and Parkin: Links to parkinsonism. Cold Spring Harb Perspect Biol 4: a011338.
71. Narkar VA, Downes M, Yu RT, Embler E, Wang YX, Banayo E, Mihaylova MM, Nelson MC, Zou Y, Juguilon H, et al. 2008. AMPK and PPARd agonists are exercise mimetics. Cell 134: 405-415.
72. Nasrin N, Wu X, Fortier E, Feng Y, Bare OC, Chen S, Ren X, Wu Z, Streeper RS, Bordone L. 2010. SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. J Biol Chem 285: 31995-32002.
73. Owusu-Ansah E, Yavari A, Mandal S, Banerjee U. 2008. Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpoint. Nat Genet 40: 356-361.
74. Park SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, et al. 2012. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148: 421-433.
75. Peralta S, Wang X, Morales CT. 2012. Mitochondrial transcription: Lessons from mouse models. Biochim Biophys Acta 1819: 961-969.
76. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI. 2003. Mitochondrial dysfunction in the elderly: Possible role in insulin resistance. Science 300: 1140-1142.
77. Price NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, et al. 2012. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab 15: 675-690.
78. Puigserver P, Spiegelman BM. 2003. Peroxisome proliferator-activated receptor-g coactivator 1a (PGC-1a): Transcriptional coactivator and metabolic regulator. Endocr Rev 24: 78-90.
79. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. 1998. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92: 829-839.
80. Purushotham A, Schug TT, Xu Q, Surapureddi S, Guo X, Li X. 2009. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab 9: 327-338.
81. Rasbach KA, Gupta RK, Ruas JL, Wu J, Naseri E, Estall JL, Spiegelman BM. 2010. PGC-1a regulates a HIF2a-dependent switch in skeletal muscle fiber types. Proc Natl Acad Sci 107: 21866-21871.
82. Rebelo AP, Dillon LM, Moraes CT. 2011. Mitochondrial DNA transcription regulation and nucleoid organization. J Inherit Metabol Dis 34: 941-951.
83. Reznick RM, Zong H, Li J, Morino K, Moore IK, Yu HJ, Liu ZX, Dong J, Mustard KJ, Hawley SA, et al. 2007. Agingassociated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. Cell Metab 5: 151-156.
84. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. 2005. Nutrient control of glucose homeostasis through a complex of PGC-1a and SIRT1. Nature 434: 113-118.
85. Salih DA, Brunet A. 2008. FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr Opin Cell Biol 20: 126-136.
86. Scarpulla RC. 2008. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev 88: 611-638.
87. Scarpulla RC, Vega RB, Kelly DP. 2012. Transcriptional integration of mitochondrial biogenesis. Trends Endocrinol Metab: 23: 459-466.
88. Schieke SM, Phillips D, McCoy JP Jr, Aponte AM, Shen RF, Balaban RS, Finkel T. 2006. The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J Biol Chem 281: 27643-27652.
89. Schmidt O, Pfanner N, Meisinger C. 2010. Mitochondrial protein import: From proteomics to functional mechanisms. Nat Rev Mol Cell Biol 11: 655-667.
90. Schreiber SN, Emter R, Hock MB, Knutti D, Cardenas J, Podvinec M, Oakeley EJ, Kralli A. 2004. The estrogenrelated receptor a (ERRa) functions in PPARg coactivator 1a (PGC-1a)-induced mitochondrial biogenesis. Proc Natl Acad Sci 101: 6472-6477.
91. Seale P, Kajimura S, Yang W, Chin S, Rohas LM, Uldry M, Tavernier G, Langin D, Spiegelman BM. 2007. Transcriptional control of brown fat determination by PRDM16. Cell Metab 6: 38-54.
92. Sengupta S, Peterson TR, Laplante M, Oh S, Sabatini DM. 2010. mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature 468: 1100-1104.
93. Shin JH, Ko HS, Kang H, Lee Y, Lee YI, Pletinkova O, Troconso JC, Dawson VL, Dawson TM. 2011. PARIS (ZNF746) repression of PGC-1a contributes to neurodegeneration in Parkinson's disease. Cell 144: 689-702.
94. Silva JE. 1995. Thyroid hormone control of thermogenesis and energy balance. Thyroid 5: 481-492.
95. Sohal RS, Weindruch R. 1996. Oxidative stress, caloric restriction, and aging. Science 273: 59-63.
96. Soriano FX, Liesa M, Bach D, Chan DC, Palacin M, Zorzano A. 2006. Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1a, estrogen-related receptor-a, and mitofusin 2. Diabetes 55: 1783-1791.
97. Spindler SR. 2001. Calorie restriction enhances the expression of key metabolic enzymes associated with protein renewal during aging. Ann NYAcad Sci 928: 296-304.
98. Srivastava S, Diaz F, Iommarini L, Aure K, Lombes A, Moraes CT. 2009. PGC-1a/b induced expression partially compensates for respiratory chain defects in cells from patients with mitochondrial disorders. Hum Mol Genet 18: 1805-1812.
99. Stowers RS, Megeath LJ, Gorska-Andrzejak J, Meinertzhagen IA, Schwarz TL. 2002. Axonal transport of mitochondria to synapses depends on milton, a novel Drosophila protein. Neuron 36: 1063-1077.
100. Twig G, Hyde B, Shirihai OS. 2008. Mitochondrial fusion, fission and autophagy as a quality control axis: The bioenergetic view. Biochim Biophys Acta 1777: 1092-1097.
101. Uldry M, YangW, St-Pierre J, Lin J, Seale P, Spiegelman BM. 2006. Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation. Cell Metab 3: 333-341.
102. Venditti P, Bari A, Di Stefano L, Cardone A, Della Ragione F, D'Esposito M, Di Meo S. 2009. Involvement of PGC-1, NRF-1, and NRF-2 in metabolic response by rat liver to hormonal and environmental signals. Mol Cell Endocrinol 305: 22-29.
103. Verdin E, Hirschey MD, Finley LW, Haigis MC. 2010. Sirtuin regulation of mitochondria: Energy production, apoptosis, and signaling. Trends Biochem Sci 35: 669-675.
104. Viscomi C, Bottani E, Civiletto G, Cerutti R, Moggio M, Fagiolari G, Schon EA, Lamperti C, Zeviani M. 2011. In vivo correction of COX deficiency by activation of the AMPK/PGC-1a axis. Cell Metab 14: 80-90.
105. Wallace DC, Fan W. 2009. The pathophysiology of mitochondrial disease as modeled in the mouse. Genes Dev 23: 1714-1736.
106. Wang X, Winter D, Ashrafi G, Schlehe J, Wong YL, Selkoe D, Rice S, Steen J, LaVoie MJ, Schwarz TL. 2011. PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147: 893-906.
107. Wenz T, Diaz F, Spiegelman BM, Moraes CT. 2008. Activation of the PPAR/PGC-1a pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab 8: 249-256.
108. Wenz T, Rossi SG, Rotundo RL, Spiegelman BM, Moraes CT. 2009. Increased muscle PGC-1a expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci 106: 20405-20410.
109. Westermann B. 2010. Mitochondrial fusion and fission in cell life and death. Nat Rev Mol Cell Biol 11: 872-884.
110. Wilson BJ, Tremblay AM, Deblois G, Sylvain-Drolet G, Giguere V. 2010. An acetylation switch modulates the transcriptional activity of estrogen-related receptor a. Mol Endocrinol 24: 1349-1358.
111. Wilson-Fritch L, Nicoloro S, Chouinard M, Lazar MA, Chui PC, Leszyk J, Straubhaar J, Czech MP, Corvera S. 2004. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest 114: 1281-1289.
112. Wright DC, Geiger PC, Han DH, Jones TE, Holloszy JO. 2007. Calcium induces increases in peroxisome proliferator-activated receptor g coactivator-1a and mitochondrial biogenesis by a pathway leading to p38 mitogenactivated protein kinase activation. J Biol Chem 282: 18793-18799.
113. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, et al. 1999. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98: 115-124.
114. Wu H, Kanatous SB, Thurmond FA, Gallardo T, Isotani E, Bassel-Duby R, Williams RS. 2002. Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science 296: 349-352.
115. Yan Z, Okutsu M, Akhtar YN, Lira VA. 2011. Regulation of exercise-induced fiber type transformation, mitochondrial biogenesis, and angiogenesis in skeletal muscle. J Appl Physiol 110: 264-274.
116. Yatsuga S, Suomalainen A. 2012. Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice. Hum Mol Genet 21: 526-535.
117. Youle RJ, van der Bliek AM. 2012. Mitochondrial fission, fusion, and stress. Science 337: 1062-1065.
118. Yu W, Dittenhafer-Reed KE, Denu JM. 2012. SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status. J Biol Chem 287: 14078-14086.
119. Zhao Q, Wang J, Levichkin IV, Stasinopoulos S, Ryan MT, Hoogenraad NJ. 2002. A mitochondrial specific stress response in mammalian cells. EMBO J 21: 4411-4419.
120. Zheng B, Liao Z, Locascio JJ, Lesniak KA, Roderick SS, Watt ML, Eklund AC, Zhang-James Y, Kim PD, Hauser MA, et al. 2010. PGC-1a, a potential therapeutic target for early intervention in Parkinson's disease. Sci Transl Med 2: 52ra73.
121. Zoncu R, Efeyan A, Sabatini DM. 2011. mTOR: From growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12: 21-35.